Synta Pharmaceuticals CEO Paul Friedman's 2019 pay rises 8% to $6.1M
Synta Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Synta Pharmaceuticals reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, five executives at Synta Pharmaceuticals received on average a compensation package of $4.6M, a 4% increase compared to previous year.
Average pay of disclosed executives at Synta Pharmaceuticals
Paul A. Friedman, Chief Executive Officer, received $6.1M in total, which increased by 8% compared to 2018. 84% of Friedman's compensation, or $5.1M, was in option awards. Friedman also received $387K in non-equity incentive plan and $584K in salary.
For fiscal year 2019, the median employee pay was $791,000 at Synta Pharmaceuticals. Therefore, the ratio of Paul A. Friedman's pay to the median employee pay was 8 to one.
Rebecca Taub, Chief Medical Officer, received a compensation package of $5.3M, which increased by 21% compared to previous year. 86% of the compensation package, or $4.5M, was in option awards.
Brian J. Lynch, General Counsel, earned $4.1M in 2019.
Brian J Lynch, General Counsel, received $4.1M in 2019.
Marc R. Schneebaum, Chief Financial Officer, earned $3.5M in 2019, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.